Literature DB >> 23424909

[Drug reaction with eosinophilia and systemic symptoms (DRESS)].

Vincent Descamps1.   

Abstract

DRESS (drug reaction with Eosinophilia and systemic symptoms) is a syndrome classically considered as a severe cutaneous drug adverse reaction. But visceral manifestations (renal, liver, lung, heart...) may be at the forefront. It presents clinically as an exanthema evolving to erythroderma with facial edema, associated with lymphadenopathy, high fever, visceral involvement (hepatitis, renal failure, pneumonitis, or hemophagocytic syndrome), eosinophilia preceded by lymphopenia and/or atypical lymphocytes. DRESS is characterized by a long delay between the first drug intake and its development (2 weeks to 3 months) and by its long course (more than 2 weeks) with flares even after drug discontinuation. Its pathophysiology is unique: it is the consequence of the immune response against Herpesvirus (HHV6, EBV, CMV) reactivation. It is induced by some drugs (allopurinol, anticonvulsants, sulfasalazine, minocycine...). Its early diagnosis is necessary for a rapid discontinuation of the culprit drug. Its management includes a long-term followup, and according to the severity either topical steroids, systemic steroids, intravenous gammaglobulins, or antiviral.

Entities:  

Mesh:

Year:  2012        PMID: 23424909

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  3 in total

1.  Comment on: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Singapore Med J       Date:  2018-05       Impact factor: 1.858

2.  DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin.

Authors:  Justyna Janocha-Litwin; Monika Pazgan-Simon; Krzysztof Simon
Journal:  Postepy Dermatol Alergol       Date:  2014-12-03       Impact factor: 1.837

3.  Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study.

Authors:  Jia-Jin Chen; George Kuo; Pei-Chun Fan; Tao-Han Lee; Chieh-Li Yen; Cheng-Chia Lee; Ya-Chung Tian; Chih-Hsiang Chang
Journal:  J Nephrol       Date:  2021-10-08       Impact factor: 4.393

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.